annual cash & cash equivalents:
$25.61M+$1.34M(+5.53%)Summary
- As of today (July 1, 2025), LMAT annual cash & cash equivalents is $25.61 million, with the most recent change of +$1.34 million (+5.53%) on December 31, 2024.
- During the last 3 years, LMAT annual cash & cash equivalents has risen by +$11.76 million (+84.84%).
- LMAT annual cash & cash equivalents is now -6.71% below its all-time high of $27.45 million, reached on December 31, 2015.
Performance
LMAT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$25.34M-$270.00K(-1.05%)Summary
- As of today (July 1, 2025), LMAT quarterly cash & cash equivalents is $25.34 million, with the most recent change of -$270.00 thousand (-1.05%) on March 31, 2025.
- Over the past year, LMAT quarterly cash & cash equivalents has dropped by -$1.25 million (-4.72%).
- LMAT quarterly cash & cash equivalents is now -32.45% below its all-time high of $37.51 million, reached on September 30, 2017.
Performance
LMAT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LMAT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -4.7% |
| 3 y3 years | +84.8% | +62.9% |
| 5 y5 years | +117.3% | +131.5% |
LMAT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +84.8% | -4.7% | +52.0% |
| 5 y | 5-year | -4.3% | +117.3% | -13.4% | +82.9% |
| alltime | all time | -6.7% | +7499.4% | -32.5% | +5493.8% |
LMAT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $25.34M(-1.1%) |
| Dec 2024 | $25.61M(+5.5%) | $25.61M(+21.9%) |
| Sep 2024 | - | $21.00M(-5.7%) |
| Jun 2024 | - | $22.27M(-16.3%) |
| Mar 2024 | - | $26.59M(+9.6%) |
| Dec 2023 | $24.27M(+26.8%) | $24.27M(+34.4%) |
| Sep 2023 | - | $18.05M(-7.4%) |
| Jun 2023 | - | $19.49M(+16.9%) |
| Mar 2023 | - | $16.68M(-12.8%) |
| Dec 2022 | $19.13M(+38.1%) | $19.13M(+13.1%) |
| Sep 2022 | - | $16.91M(-18.6%) |
| Jun 2022 | - | $20.79M(+33.6%) |
| Mar 2022 | - | $15.56M(+12.3%) |
| Dec 2021 | $13.86M(-48.2%) | $13.86M(-20.2%) |
| Sep 2021 | - | $17.37M(-19.4%) |
| Jun 2021 | - | $21.54M(-8.4%) |
| Mar 2021 | - | $23.52M(-12.1%) |
| Dec 2020 | $26.76M(+127.1%) | $26.76M(-8.6%) |
| Sep 2020 | - | $29.28M(+46.6%) |
| Jun 2020 | - | $19.98M(+82.5%) |
| Mar 2020 | - | $10.94M(-7.1%) |
| Dec 2019 | $11.79M(-55.2%) | $11.79M(+0.6%) |
| Sep 2019 | - | $11.72M(-11.6%) |
| Jun 2019 | - | $13.26M(-10.2%) |
| Mar 2019 | - | $14.77M(-43.9%) |
| Dec 2018 | $26.32M(+37.8%) | $26.32M(+30.9%) |
| Sep 2018 | - | $20.10M(+2.4%) |
| Jun 2018 | - | $19.64M(-13.8%) |
| Mar 2018 | - | $22.78M(+19.3%) |
| Dec 2017 | $19.10M(-21.4%) | $19.10M(-49.1%) |
| Sep 2017 | - | $37.51M(+24.5%) |
| Jun 2017 | - | $30.12M(+16.7%) |
| Mar 2017 | - | $25.81M(+6.3%) |
| Dec 2016 | $24.29M(-11.5%) | $24.29M(-29.9%) |
| Sep 2016 | - | $34.65M(+18.2%) |
| Jun 2016 | - | $29.32M(+13.0%) |
| Mar 2016 | - | $25.94M(-5.5%) |
| Dec 2015 | $27.45M | $27.45M(+16.2%) |
| Sep 2015 | - | $23.63M(+21.6%) |
| Jun 2015 | - | $19.43M(+14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $17.02M(-8.9%) |
| Dec 2014 | $18.69M(+27.1%) | $18.69M(+1.8%) |
| Sep 2014 | - | $18.35M(-21.9%) |
| Jun 2014 | - | $23.51M(+88.0%) |
| Mar 2014 | - | $12.50M(-15.0%) |
| Dec 2013 | $14.71M(-10.6%) | $14.71M(+8.0%) |
| Sep 2013 | - | $13.63M(-8.6%) |
| Jun 2013 | - | $14.91M(-2.6%) |
| Mar 2013 | - | $15.30M(-7.0%) |
| Dec 2012 | $16.45M(-18.3%) | $16.45M(-20.3%) |
| Sep 2012 | - | $20.64M(+2.4%) |
| Jun 2012 | - | $20.16M(+2.8%) |
| Mar 2012 | - | $19.62M(-2.5%) |
| Dec 2011 | $20.13M(-11.0%) | $20.13M(-12.8%) |
| Sep 2011 | - | $23.09M(+7.9%) |
| Jun 2011 | - | $21.41M(+12.1%) |
| Mar 2011 | - | $19.10M(-15.5%) |
| Dec 2010 | $22.61M(-2.5%) | $22.61M(-17.6%) |
| Sep 2010 | - | $27.45M(+7.2%) |
| Jun 2010 | - | $25.61M(+8.2%) |
| Mar 2010 | - | $23.66M(+2.0%) |
| Dec 2009 | $23.19M(+45.9%) | $23.19M(+17.1%) |
| Sep 2009 | - | $19.81M(+18.3%) |
| Jun 2009 | - | $16.74M(+18.8%) |
| Mar 2009 | - | $14.09M(-11.3%) |
| Dec 2008 | $15.89M(+148.5%) | $15.89M(+20.8%) |
| Sep 2008 | - | $13.16M(+23.6%) |
| Jun 2008 | - | $10.65M(+95.6%) |
| Mar 2008 | - | $5.44M(-14.9%) |
| Dec 2007 | $6.40M(-58.4%) | $6.40M(-17.5%) |
| Sep 2007 | - | $7.75M(-37.9%) |
| Jun 2007 | - | $12.47M(-5.8%) |
| Mar 2007 | - | $13.24M(-14.0%) |
| Dec 2006 | $15.39M(+1783.8%) | $15.39M(+3297.6%) |
| Sep 2006 | - | $453.00K(-32.0%) |
| Jun 2006 | - | $666.00K(+42.0%) |
| Mar 2006 | - | $469.00K(-42.6%) |
| Dec 2005 | $817.00K(+12.8%) | $817.00K(+12.8%) |
| Dec 2004 | $724.00K(+114.8%) | $724.00K |
| Dec 2002 | $337.00K | - |
FAQ
- What is LeMaitre Vascular annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LeMaitre Vascular?
- What is LeMaitre Vascular annual cash & cash equivalents year-on-year change?
- What is LeMaitre Vascular quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly cash & cash equivalents year-on-year change?
What is LeMaitre Vascular annual cash & cash equivalents?
The current annual cash & cash equivalents of LMAT is $25.61M
What is the all time high annual cash & cash equivalents for LeMaitre Vascular?
LeMaitre Vascular all-time high annual cash & cash equivalents is $27.45M
What is LeMaitre Vascular annual cash & cash equivalents year-on-year change?
Over the past year, LMAT annual cash & cash equivalents has changed by +$1.34M (+5.53%)
What is LeMaitre Vascular quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LMAT is $25.34M
What is the all time high quarterly cash & cash equivalents for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly cash & cash equivalents is $37.51M
What is LeMaitre Vascular quarterly cash & cash equivalents year-on-year change?
Over the past year, LMAT quarterly cash & cash equivalents has changed by -$1.25M (-4.72%)